Avantor (AVTR)

NYSE Health Care Life Sciences Tools & Services S&P MidCap 400

$15.47

+0.33 (+2.18%)

Close of Nov 06, 2026 · end-of-day data

Source: Avantor's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.25B	$5.86B	$6.04B	$6.39B	$7.39B	$7.51B	$6.97B	$6.78B	$6.55B
Cost of revenue	$814.60M	$4.04B	$4.12B	$4.31B	$4.88B	$4.91B	$4.60B	$4.50B	$4.41B
Gross profit	$432.80M	$1.82B	$1.92B	$2.08B	$2.50B	$2.60B	$2.36B	$2.28B	$2.14B
Selling, general & admin	$449.70M	$1.41B	$1.37B	$1.37B	$1.53B	$1.47B	$1.51B	$1.64B	$1.60B
Operating income	-$210.40M	$413.50M	$551.80M	$706.80M	$972.20M	$1.13B	$696.40M	$1.08B	-$246.20M
Interest expense	$200.90M	$523.80M	$440.00M	$307.60M	$217.40M	$265.80M	$284.80M	$218.80M	$169.80M
Pre-tax income	-$460.20M	-$113.80M	$40.60M	$62.30M	$753.00M	$851.10M	$410.50M	$853.90M	-$441.30M
Income tax	-$314.90M	-$26.90M	$2.80M	-$54.30M	$180.40M	$164.60M	$89.40M	$142.40M	$88.90M
Net income	-$112.70M	-$86.90M	$37.80M	$116.60M	$572.60M	$686.50M	$321.10M	$711.50M	-$530.20M
EBITDA	-$111.20M	$818.10M	$950.70M	$1.10B	$1.35B	$1.54B	$1.10B	$1.49B	$164.00M
EPS (basic)	$-2.75	$-2.69	$-0.84	$0.09	$0.86	$1.02	$0.48	$1.05	$-0.78
EPS (diluted)	$-2.75	$-2.69	$-0.84	$0.09	$0.85	$1.01	$0.47	$1.04	$-0.78
Diluted shares	151.10M	132.70M	401.20M	583.40M	599.60M	679.40M	678.40M	681.90M	680.60M
Gross margin	34.7%	31.0%	31.8%	32.5%	33.9%	34.6%	33.9%	33.6%	32.7%
Operating margin	-16.9%	7.1%	9.1%	11.1%	13.2%	15.0%	10.0%	16.0%	-3.8%
Net margin	-9.0%	-1.5%	0.6%	1.8%	7.8%	9.1%	4.6%	10.5%	-8.1%

Balance sheet

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$188.50M	$184.70M	$186.70M	$286.60M	$301.70M	$372.90M	$262.90M	$261.90M	$365.40M
Receivables	—	$931.20M	$988.80M	$1.11B	$1.22B	$1.22B	$1.15B	$1.03B	$1.07B
Inventory	—	$671.10M	$711.20M	$739.60M	$872.00M	$913.50M	$828.10M	$731.50M	$818.20M
Total current assets	—	$1.90B	$2.02B	$2.23B	$2.48B	$2.66B	$2.38B	$2.15B	$2.45B
Goodwill	$2.85B	$2.78B	$2.77B	$2.86B	$5.34B	$5.65B	$5.72B	$5.54B	$4.99B
Total assets	—	$9.91B	$9.77B	$9.91B	$13.90B	$13.46B	$12.97B	$12.11B	$11.79B
Total current liabilities	—	$1.10B	$1.07B	$1.24B	$1.45B	$1.66B	$1.48B	$2.01B	$1.38B
Short-term debt	—	$142.40M	$93.50M	$26.40M	$45.20M	$364.20M	$259.90M	$821.10M	$30.80M
Long-term debt	—	$6.78B	$5.02B	$4.87B	$6.98B	$5.92B	$5.28B	$3.23B	$3.92B
Total debt	—	$6.92B	$5.12B	$4.89B	$7.02B	$6.29B	$5.54B	$4.06B	$3.95B
Total liabilities	—	$9.10B	$7.31B	$7.23B	$9.70B	$8.61B	$7.72B	$6.16B	$6.23B
Shareholders' equity	-$2.62B	-$3.05B	$2.46B	$2.67B	$4.20B	$4.86B	$5.25B	$5.96B	$5.57B

Cash flow

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$167.50M	$200.50M	$354.00M	$929.80M	$953.60M	$843.60M	$870.00M	$840.80M	$623.80M
Capital expenditures	$25.20M	$37.70M	$51.60M	$61.60M	$111.10M	$133.40M	$146.40M	$148.80M	$128.80M
Free cash flow	-$192.70M	$162.80M	$302.40M	$868.20M	$842.50M	$710.20M	$723.60M	$692.00M	$495.00M
Investing cash flow	-$6.68B	-$23.20M	-$42.10M	-$59.10M	-$4.12B	-$109.60M	-$143.70M	$438.90M	-$130.50M
Financing cash flow	$6.96B	-$170.30M	-$307.80M	-$782.90M	$3.22B	-$648.70M	-$843.70M	-$1.28B	-$409.40M
Share buybacks	—	—	—	—	—	—	$0	$0	$75.10M
Stock-based compensation	$48.20M	$18.40M	$67.90M	$44.10M	$50.70M	$45.80M	$40.50M	$46.80M	$46.40M
Depreciation & amortization	$99.20M	$404.60M	$398.90M	$395.40M	$379.20M	$405.50M	$402.30M	$405.50M	$410.20M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$1.72B	$1.68B	$1.70B	$1.71B	$1.69B	$1.58B	$1.68B	$1.62B	$1.66B	$1.58B	$1.69B	$1.70B
Cost of revenue	$1.15B	$1.11B	$1.12B	$1.15B	$1.12B	$1.05B	$1.13B	$1.10B	$1.14B	$1.08B	$1.16B	$1.16B
Gross profit	$570.40M	$570.50M	$581.50M	$564.40M	$562.90M	$534.90M	$554.10M	$526.50M	$523.90M	$500.70M	$537.00M	$534.80M
Selling, general & admin	$387.10M	$424.20M	$405.70M	$439.80M	$371.40M	$387.50M	$425.30M	$390.30M	$392.40M	$401.20M	$415.20M	$395.30M
Operating income	$183.30M	$146.30M	$175.80M	$124.60M	$638.10M	$147.40M	$128.80M	-$648.80M	$126.40M	$99.50M	$121.80M	$139.50M
Interest expense	$65.30M	$64.30M	$60.90M	$48.70M	$44.90M	$42.20M	$43.40M	$44.20M	$40.00M	$42.90M	$39.40M	$39.90M
Pre-tax income	$119.50M	$80.60M	$114.60M	$74.50M	$584.20M	$85.70M	$81.70M	-$689.50M	$80.80M	$55.50M	$81.20M	$98.00M
Income tax	$21.00M	$20.20M	$21.70M	$16.70M	$83.80M	$21.20M	$17.00M	$22.30M	$28.40M	$12.20M	$43.10M	-$105.40M
Net income	$98.50M	$60.40M	$92.90M	$57.80M	$500.40M	$64.50M	$64.70M	-$711.80M	$52.40M	$43.30M	$38.10M	$203.40M
EBITDA	$283.90M	$245.90M	$278.40M	$227.00M	$739.00M	$247.10M	$231.50M	-$544.30M	$229.70M	$204.50M	$227.40M	$244.80M
EPS (basic)	$0.15	$0.09	$0.14	$0.08	$0.74	$0.09	$0.09	$-1.04	$0.08	$0.06	$0.06	$0.30
EPS (diluted)	$0.14	$0.09	$0.14	$0.08	$0.73	$0.09	$0.09	$-1.04	$0.08	$0.06	$0.06	$0.30
Diluted shares	300.00K	681.40M	682.60M	683.00M	-200.00K	682.40M	681.80M	681.70M	-800.00K	676.80M	677.20M	680.90M
Gross margin	33.1%	34.0%	34.1%	32.9%	33.4%	33.8%	32.9%	32.4%	31.5%	31.7%	31.7%	31.5%
Operating margin	10.6%	8.7%	10.3%	7.3%	37.8%	9.3%	7.7%	-40.0%	7.6%	6.3%	7.2%	8.2%
Net margin	5.7%	3.6%	5.5%	3.4%	29.7%	4.1%	3.8%	-43.8%	3.1%	2.7%	2.3%	12.0%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$262.90M	$234.90M	$272.60M	$285.30M	$261.90M	$315.70M	$449.40M	$251.90M	$365.40M	$279.30M	$306.80M	$464.30M
Receivables	$1.15B	$1.13B	$1.13B	$1.09B	$1.03B	$1.10B	$1.15B	$1.08B	$1.07B	$1.10B	$1.14B	$1.12B
Inventory	$828.10M	$810.60M	$795.60M	$779.60M	$731.50M	$750.10M	$779.80M	$795.50M	$818.20M	$810.30M	$828.70M	$854.80M
Total current assets	$2.38B	$2.32B	$2.33B	$2.50B	$2.15B	$2.28B	$2.51B	$2.26B	$2.45B	$2.40B	$2.46B	$2.59B
Goodwill	$5.72B	$5.67B	$5.66B	$5.67B	$5.54B	$5.61B	$5.76B	$4.98B	$4.99B	$4.95B	$4.94B	$4.93B
Total assets	$12.97B	$12.76B	$12.69B	$12.84B	$12.11B	$12.33B	$12.78B	$11.68B	$11.79B	$11.66B	$11.60B	$11.63B
Total current liabilities	$1.48B	$1.44B	$1.46B	$1.63B	$2.01B	$2.03B	$2.58B	$1.52B	$1.38B	$1.37B	$1.38B	$1.37B
Short-term debt	$259.90M	$299.10M	$258.40M	$229.70M	$821.10M	$827.50M	$1.25B	$219.80M	$30.80M	$37.00M	$37.00M	$35.00M
Long-term debt	$5.28B	$5.02B	$4.86B	$4.69B	$3.23B	$3.28B	$2.99B	$3.64B	$3.92B	$3.78B	$3.66B	$3.65B
Total debt	$5.54B	$5.32B	$5.12B	$4.92B	$4.06B	$4.11B	$4.24B	$3.86B	$3.95B	$3.82B	$3.70B	$3.68B
Total liabilities	$7.72B	$7.43B	$7.26B	$7.29B	$6.16B	$6.23B	$6.49B	$6.11B	$6.23B	$6.07B	$5.97B	$5.79B
Shareholders' equity	$5.25B	$5.34B	$5.43B	$5.55B	$5.96B	$6.10B	$6.29B	$5.57B	$5.57B	$5.59B	$5.63B	$5.84B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$251.60M	$141.60M	$281.10M	$244.80M	$173.30M	$109.30M	$154.40M	$207.40M	$152.70M	$58.70M	$178.20M	$195.10M
Capital expenditures	$50.60M	$34.70M	$45.80M	$40.80M	$27.50M	$28.00M	$29.60M	$35.70M	$35.50M	$33.50M	$37.60M	$38.90M
Free cash flow	$201.00M	$106.90M	$235.30M	$204.00M	$145.80M	$81.30M	$124.80M	$171.70M	$117.20M	$25.20M	$140.60M	$156.20M
Investing cash flow	-$50.00M	-$34.20M	-$44.90M	-$40.50M	$558.50M	-$28.90M	-$28.60M	-$33.30M	-$39.70M	-$32.70M	-$37.30M	-$38.50M
Financing cash flow	-$184.10M	-$130.20M	-$197.10M	-$198.60M	-$755.30M	-$33.60M	-$6.90M	-$369.60M	$700.00K	-$107.20M	-$112.40M	$1.80M
Stock-based compensation	$8.80M	$12.70M	$11.10M	$11.90M	$11.10M	$12.40M	$15.50M	$7.20M	$11.30M	$8.60M	$15.40M	$12.50M
Depreciation & amortization	$100.60M	$99.60M	$102.60M	$102.40M	$100.90M	$99.70M	$102.70M	$104.50M	$103.30M	$105.00M	$105.60M	$105.30M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.